Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A Ciulla

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
Expert Opinion on Emerging Drugs|August 1, 2017
Emerging vascular endothelial growth factor antagonists to treat neovascular age-related macular degenerationRehan M Hussain, Thomas A Ciulla
Current Opinion in Ophthalmology|May 7, 2009
Antivascular endothelial growth factor therapy for neovascular age-related macular degenerationThomas A Ciulla, Philip J Rosenfeld
Expert Opinion on Drug Delivery|December 6, 2024
Suprachoroidal drug delivery: a versatile therapeutic platformThomas A Ciulla, Emmett T Cunningham
Expert Opinion on Biological Therapy|December 18, 2015
Treatment strategies for refractory diabetic macular edema: switching anti-VEGF treatments, adopting corticosteroid-based treatments, and combination therapyRehan M Hussain, Thomas A Ciulla
Expert Opinion on Emerging Drugs|June 7, 2005
Current and future pharmacological intervention for diabetic retinopathyGrant M Comer, Thomas A Ciulla
American Journal of Ophthalmology|October 19, 2004
Macular pigment density and aging, assessed in the normal elderly and those with cataracts and age-related macular degenerationThomas A Ciulla, Billy R Hammond
Expert Opinion on Biological Therapy|July 2, 2024
Long-acting delivery and therapies for neovascular age-related macular degenerationLucas W Rowe, Thomas A Ciulla
Expert Opinion on Biological Therapy|September 5, 2022
Advancements in ocular gene therapy delivery: vectors and subretinal, intravitreal, and suprachoroidal techniquesKyle D Kovacs, Thomas A Ciulla, Szilárd Kiss
Diabetes Care|August 28, 2003
Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapiesThomas A Ciulla, Armando G Amador, Bernard Zinman
Ophthalmology|January 5, 2002
Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based updateThomas A Ciulla, Michael B Starr, Samuel Masket
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Expert Opinion on Emerging Drugs|August 1, 2017
Emerging vascular endothelial growth factor antagonists to treat neovascular age-related macular degenerationRehan M Hussain, Thomas A Ciulla
Current Opinion in Ophthalmology|May 7, 2009
Antivascular endothelial growth factor therapy for neovascular age-related macular degenerationThomas A Ciulla, Philip J Rosenfeld
Expert Opinion on Drug Delivery|December 6, 2024
Suprachoroidal drug delivery: a versatile therapeutic platformThomas A Ciulla, Emmett T Cunningham
Expert Opinion on Biological Therapy|December 18, 2015
Treatment strategies for refractory diabetic macular edema: switching anti-VEGF treatments, adopting corticosteroid-based treatments, and combination therapyRehan M Hussain, Thomas A Ciulla
Expert Opinion on Emerging Drugs|June 7, 2005
Current and future pharmacological intervention for diabetic retinopathyGrant M Comer, Thomas A Ciulla
American Journal of Ophthalmology|October 19, 2004
Macular pigment density and aging, assessed in the normal elderly and those with cataracts and age-related macular degenerationThomas A Ciulla, Billy R Hammond
Expert Opinion on Biological Therapy|July 2, 2024
Long-acting delivery and therapies for neovascular age-related macular degenerationLucas W Rowe, Thomas A Ciulla
Expert Opinion on Biological Therapy|September 5, 2022
Advancements in ocular gene therapy delivery: vectors and subretinal, intravitreal, and suprachoroidal techniquesKyle D Kovacs, Thomas A Ciulla, Szilárd Kiss
Diabetes Care|August 28, 2003
Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapiesThomas A Ciulla, Armando G Amador, Bernard Zinman
Ophthalmology|January 5, 2002
Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based updateThomas A Ciulla, Michael B Starr, Samuel Masket
Pageof 12